Lamivudine plus tenofovir versus lamivudine plus adefovir for the treatment of hepatitis B virus in HIV-coinfected patients, starting antiretroviral therapy

Conclusions: Adefovir plus lamivudine is an effective alternative of tenofovir plus lamivudine in long-term HBV treatment outcome in HIV/HBV coinfected patients.

Source: Indian Journal of Medical Microbiology - August 7, 2018 Category: Microbiology Authors: Jayeeta Sarkar Debraj Saha Bhaswati Bandyopadhyay Bibhuti Saha Runu Chakravarty Subhasish Kamal Guha Source Type: research